The FY2025 (Dec) proxy of Ani Pharmaceuticals names 17 peer companies for pay. Pay versus performance data of Ani Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| TG Therapeutics | ||
| PTC Therapeutics | ||
| Supernus Pharmaceuticals | ||
| INSMED | ||
| Ultragenyx Pharmaceutical | ||
| Travere Therapeutics | ||
| Aurinia Pharmaceuticals | ||
| Collegium Pharmaceutical | ||
| Acadia Pharmaceuticals | Not disclosed | Not disclosed |
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Amphastar Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Myriad Genetics, Inc. | Not disclosed | Not disclosed |
| Pacira BioSciences | Not disclosed | Not disclosed |
17 companies
PSU comparator group
The companies that relative total shareholder return is measured against for performance stock units.
| S&P 600 Pharmaceuticals (index) | Not disclosed | Not disclosed |
1 company
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.